Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Our AI ranks Precision Optics Corporation, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Precision Optics Corporation, Inc. is a small-cap company with a market capitalization of $34M. It ranks number 22 by market capitalization among the 30 Electromedical & Electrotherapeutic Apparatus issuers in our coverage with a current forecast.
For POCI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 24.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 15.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.1%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, POCI included.
Follow POCI free90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Electromedical & Electrotherapeutic Apparatus peers listed below that report each metric.
| Metric | POCI | Rank |
|---|---|---|
| Market Cap | $34M | 22/30 |
| P/B Ratio | 1.65x | 18/23 |
| EPS | $-0.64 | – |
| Book Value/Share | $2.61 | – |
| Revenue/Share | $4.91 | – |
| Metric | POCI | Rank |
|---|---|---|
| ROE | -25.9% | 11/19 |
| ROA | -16.3% | 12/24 |
| ROIC | -21.7% | 15/23 |
| Gross Margin | 16.7% | 25/27 |
| Operating Margin | -13.4% | 15/28 |
| Net Margin | -13.8% | 13/22 |
| EBT Margin | -13.7% | 15/28 |
| Metric | POCI | Rank |
|---|---|---|
| Current Ratio | 2.28x | 15/30 |
| Quick Ratio | 1.84x | 14/29 |
| D/E Ratio | 0.59x | 15/25 |
| Financial Leverage | 1.59x | 15/25 |
| Interest Coverage | -30.3x | 17/30 |
| Working Capital | $11M | 18/29 |
| Metric | POCI | Rank |
|---|---|---|
| Operating Cash Flow | -$1M | 14/30 |
| Metric | POCI | Rank |
|---|---|---|
| Asset Turnover | 1.18x | 2/19 |
| Receivables Turnover | 6.4x | 8/20 |
| Inventory Turnover | 8.3x | 3/27 |
| Fixed Assets Turnover | 43.0x | 6/20 |
| Days Sales Outstanding | 57 days | 13/20 |
| Days Inventory | 44 days | 25/27 |
| Payables Period | 41 days | 19/24 |
| Cash Conversion Cycle | 60 days | 13/19 |
| Metric | POCI | Rank |
|---|---|---|
| Total Revenue | $38M | 11/19 |
| Operating Income | -$5M | 17/30 |
| Net Income | -$5M | 15/24 |
| R&D Expense | $1M | 21/28 |
| SG&A Expense | $10M | 20/26 |
| Cost of Goods Sold | $32M | 11/27 |
| Metric | POCI | Rank |
|---|---|---|
| Shares Outstanding | 8M | – |
| Total Current Assets | $20M | 62.2% of assets |
| Cash & Short-term Investments | $10M | 30.4% of assets |
| Accounts Receivable | $6M | 18.4% of assets |
| Inventory | $4M | 11.8% of assets |
| Total Liabilities | $12M | 37.1% of assets |
| Short-term Debt | $5M | 16.2% of assets |
Companies classified under the same SEC industry code as Precision Optics Corporation, Inc. (Electromedical & Electrotherapeutic Apparatus): 32 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| POCI Precision Optics Corporation, Inc. | ▲ | $34M |
| MDT Medtronic Plc | ▼ | $121.20B |
| ITGR Integer Holdings Corp | ▼ | $4.31B |
| LIVN Livanova Plc | ▼ | $4.27B |
| TMDX Transmedics Group, Inc. | ▲ | $2.45B |
| BLFS Biolife Solutions Inc | ▶ | $1.89B |
| AXGN Axogen, Inc. | ▲ | $1.86B |
| CNMD Conmed Corp | ▼ | $1.40B |
| CBLL Ceribell, Inc. | ▲ | $961M |
| INMD Inmode Ltd. | ▼ | $814M |
| CV Capsovision, Inc | ▶ | $327M |
| ELMD Electromed, Inc. | ▼ | $229M |
| FOCL Edap Tms Sa | ▲ | $153M |
| STXS Stereotaxis, Inc. | ▶ | $101M |
| VANI Vivani Medical, Inc. | ▶ | $101M |
| NRXS Neuraxis, Inc | ▲ | $97M |
| HYPR Hyperfine, Inc. | ▲ | $75M |
| OM Outset Medical, Inc. | ▲ | $74M |
| ECOR Electrocore, Inc. | ▲ | $71M |
| VASO Vaso Corp | ▲ | $51M |
| POSC Positron Corp | ▲ | $51M |
| QTI Qt Imaging Holdings, Inc. | ▶ | $35M |
| ITOC Itonic Holdings Ltd | ▶ | $28M |
| GTHP Guided Therapeutics Inc | ▲ | $18M |
| IRIX Iridex Corp | ▲ | $14M |
| NDRA Endra Life Sciences Inc. | ▶ | $7M |
| ADMT Adm Tronics Unlimited, Inc. | ▼ | $3M |
| NUWE Nuwellis, Inc. | ▶ | $2M |
| NXL Nexalin Technology, Inc. | ▼ | $2M |
| ESMC Escalon Medical Corp | ▶ | $1M |
| HCIL Hongchang International Co., Ltd | ▶ | N/A |
| YBGJ Yubo International Biotech Ltd | ▶ | N/A |
Good day, and welcome to the Precision Optics report's Second Quarter Fiscal Year 2025 Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. Please note ...
GARDNER, Mass., March 27, 2026 (GLOBE NEWSWIRE)-- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and ...
Precision Optics reports Q2 2025 revenue of $4.5 million, a net loss of $1.0 million, and launched the Unity Imaging Platform. Precision Optics Corporation, Inc. reported its second-quarter fiscal ...
Our AI ranks Precision Optics Corporation, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
For POCI, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 24.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 15.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Precision Optics Corporation, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
32 issuers in our coverage, POCI included, share the SEC industry code Electromedical & Electrotherapeutic Apparatus. The largest are: Medtronic Plc (MDT), Integer Holdings Corp (ITGR), Livanova Plc (LIVN), Transmedics Group, Inc. (TMDX), Biolife Solutions Inc (BLFS), Axogen, Inc. (AXGN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.